Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Michael Schmidt
  • Kunnel Raman Babu
  • Navin Khanna
  • Sabine Marten
  • Ursula Rinas

External Research Organisations

  • Helmholtz Centre for Infection Research (HZI)
  • International Centre for Genetic Engineering and Biotechnology India
View graph of relations

Details

Original languageEnglish
Pages (from-to)71-83
Number of pages13
JournalJournal of biotechnology
Volume68
Issue number1
Publication statusPublished - 5 Feb 1999
Externally publishedYes

Abstract

The construction of expression vectors encoding either the human insulin A- or B-chains fused to a synthetic peptide and the temperature-induced expression of the recombinant genes in Escherichia coli are reported. Using this two-chain approach we also describe the separate isolation of the insulin A- and B-chains from inclusion bodies and their subsequent assembly into native human insulin. The production of the insulin fusion proteins were carried out in high-cell density fed-batch cultures using a synthetic medium with glucose as sole carbon and energy source. The expression of the recombinant genes by temperature-shift in high-cell density cultures of recombinant E. coli resulted in product yields of grams per litre of culture broth, e.g. 4.5 g of insulin B-chain fusion protein per litre of culture broth. This translates into an expression yield of about 800 mg of the insulin B-chain per litre of culture. Under similar cultivation conditions the expression yield of the insulin A-chain corresponds to approximately 600 mg per litre of culture. The metabolic burden imposed on the recombinant cells during temperature-induced production of insulin fusion proteins in high-cell density cultures is reflected in an increased respiratory activity and a reduction elf the biomass yield coefficient with respect to glucose.

Keywords

    High-cell density cultivation, Human insulin, Recombinant Escherichia coli, Temperature-inducible expression

ASJC Scopus subject areas

Cite this

Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. / Schmidt, Michael; Babu, Kunnel Raman; Khanna, Navin et al.
In: Journal of biotechnology, Vol. 68, No. 1, 05.02.1999, p. 71-83.

Research output: Contribution to journalArticleResearchpeer review

Schmidt M, Babu KR, Khanna N, Marten S, Rinas U. Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. Journal of biotechnology. 1999 Feb 5;68(1):71-83. doi: 10.1016/S0168-1656(98)00189-8
Schmidt, Michael ; Babu, Kunnel Raman ; Khanna, Navin et al. / Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli. In: Journal of biotechnology. 1999 ; Vol. 68, No. 1. pp. 71-83.
Download
@article{bcc3b3797fbb4edfa4e8b138b1e160c1,
title = "Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli",
abstract = "The construction of expression vectors encoding either the human insulin A- or B-chains fused to a synthetic peptide and the temperature-induced expression of the recombinant genes in Escherichia coli are reported. Using this two-chain approach we also describe the separate isolation of the insulin A- and B-chains from inclusion bodies and their subsequent assembly into native human insulin. The production of the insulin fusion proteins were carried out in high-cell density fed-batch cultures using a synthetic medium with glucose as sole carbon and energy source. The expression of the recombinant genes by temperature-shift in high-cell density cultures of recombinant E. coli resulted in product yields of grams per litre of culture broth, e.g. 4.5 g of insulin B-chain fusion protein per litre of culture broth. This translates into an expression yield of about 800 mg of the insulin B-chain per litre of culture. Under similar cultivation conditions the expression yield of the insulin A-chain corresponds to approximately 600 mg per litre of culture. The metabolic burden imposed on the recombinant cells during temperature-induced production of insulin fusion proteins in high-cell density cultures is reflected in an increased respiratory activity and a reduction elf the biomass yield coefficient with respect to glucose.",
keywords = "High-cell density cultivation, Human insulin, Recombinant Escherichia coli, Temperature-inducible expression",
author = "Michael Schmidt and Babu, {Kunnel Raman} and Navin Khanna and Sabine Marten and Ursula Rinas",
year = "1999",
month = feb,
day = "5",
doi = "10.1016/S0168-1656(98)00189-8",
language = "English",
volume = "68",
pages = "71--83",
journal = "Journal of biotechnology",
issn = "0168-1656",
publisher = "Elsevier",
number = "1",

}

Download

TY - JOUR

T1 - Temperature-induced production of recombinant human insulin in high-cell density cultures of recombinant Escherichia coli

AU - Schmidt, Michael

AU - Babu, Kunnel Raman

AU - Khanna, Navin

AU - Marten, Sabine

AU - Rinas, Ursula

PY - 1999/2/5

Y1 - 1999/2/5

N2 - The construction of expression vectors encoding either the human insulin A- or B-chains fused to a synthetic peptide and the temperature-induced expression of the recombinant genes in Escherichia coli are reported. Using this two-chain approach we also describe the separate isolation of the insulin A- and B-chains from inclusion bodies and their subsequent assembly into native human insulin. The production of the insulin fusion proteins were carried out in high-cell density fed-batch cultures using a synthetic medium with glucose as sole carbon and energy source. The expression of the recombinant genes by temperature-shift in high-cell density cultures of recombinant E. coli resulted in product yields of grams per litre of culture broth, e.g. 4.5 g of insulin B-chain fusion protein per litre of culture broth. This translates into an expression yield of about 800 mg of the insulin B-chain per litre of culture. Under similar cultivation conditions the expression yield of the insulin A-chain corresponds to approximately 600 mg per litre of culture. The metabolic burden imposed on the recombinant cells during temperature-induced production of insulin fusion proteins in high-cell density cultures is reflected in an increased respiratory activity and a reduction elf the biomass yield coefficient with respect to glucose.

AB - The construction of expression vectors encoding either the human insulin A- or B-chains fused to a synthetic peptide and the temperature-induced expression of the recombinant genes in Escherichia coli are reported. Using this two-chain approach we also describe the separate isolation of the insulin A- and B-chains from inclusion bodies and their subsequent assembly into native human insulin. The production of the insulin fusion proteins were carried out in high-cell density fed-batch cultures using a synthetic medium with glucose as sole carbon and energy source. The expression of the recombinant genes by temperature-shift in high-cell density cultures of recombinant E. coli resulted in product yields of grams per litre of culture broth, e.g. 4.5 g of insulin B-chain fusion protein per litre of culture broth. This translates into an expression yield of about 800 mg of the insulin B-chain per litre of culture. Under similar cultivation conditions the expression yield of the insulin A-chain corresponds to approximately 600 mg per litre of culture. The metabolic burden imposed on the recombinant cells during temperature-induced production of insulin fusion proteins in high-cell density cultures is reflected in an increased respiratory activity and a reduction elf the biomass yield coefficient with respect to glucose.

KW - High-cell density cultivation

KW - Human insulin

KW - Recombinant Escherichia coli

KW - Temperature-inducible expression

UR - http://www.scopus.com/inward/record.url?scp=0032970060&partnerID=8YFLogxK

U2 - 10.1016/S0168-1656(98)00189-8

DO - 10.1016/S0168-1656(98)00189-8

M3 - Article

C2 - 10036770

AN - SCOPUS:0032970060

VL - 68

SP - 71

EP - 83

JO - Journal of biotechnology

JF - Journal of biotechnology

SN - 0168-1656

IS - 1

ER -